Vascular calcification is recognized as a major contributor to cardiovascular disease (CVD)
in end stage renal disease (ESRD) patients. Susceptibility to vascular calcification is …

FGF23 is a bone-derived hormone that regulates systemic phosphate homeostasis, vitamin
D metabolism and α-Klotho expression through a novel bone-kidney axis. FGF23 inhibits …

Concentrations of the phosphate-regulating hormone fibroblast growth factor-23 (FGF-23)
are elevated in patients with chronic kidney disease (CKD), but whether higher plasma FGF …

The 'Focal Infection Era in Dentistry'in the late 19th and early 20th century resulted in
widespread implementation of tooth extraction and limited the progress of endodontics. The …

The discovery of fibroblast growth factor 23 (FGF-23) has expanded our understanding of
phosphate and vitamin D homeostasis and provided new insights into the pathogenesis of …

Calcification of vessels reduces their elasticity, affecting hemodynamic parameters of the
cardiovascular system. The development of arterial hypertension, cardiac hypertrophy …

Vascular calcification can occur in nearly all arterial beds and in both the medial and intimal
layers. The initiating factors and clinical consequences depend on the underlying disease …

Vascular calcification is associated with significant cardiovascular morbidity and mortality in
patients with chronic kidney disease (CKD). Factors unique to patients with CKD, such as …

Phosphorus retention occurs from higher dietary phosphorus intake relative to its renal
excretion or dialysis removal. In the gastrointestinal tract the naturally existing organic …

Arterial medial calcification is a major complication in patients with chronic kidney disease
and is a strong predictor of cardiovascular and all-cause mortality. We sought to determine …